Gregory Bailey - AGE Old Independent Chairman of the Board
| AGEDelisted Stock | USD 0.74 0.01 1.37% |
Insider
Gregory Bailey is Independent Chairman of the Board of AGE Old since 2018.
| Age | 63 |
| Tenure | 7 years |
| Phone | 510 671 8370 |
| Web | https://www.agexinc.com |
Gregory Bailey Latest Insider Activity
Tracking and analyzing the buying and selling activities of Gregory Bailey against AGE Old stock is an integral part of due diligence when investing in AGE Old. Gregory Bailey insider activity provides valuable insight into whether AGE Old is net buyers or sellers over its current business cycle. Note, AGE Old insiders must abide by specific rules, including filing SEC forms every time they buy or sell AGE Old'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Gregory Bailey over three months ago Acquisition by Gregory Bailey of 5000 shares of Biohaven Pharmaceutical at 44.1932 subject to Rule 16b-3 | ||
Gregory Bailey over six months ago Acquisition by Gregory Bailey of 16592 shares of Biohaven Pharmaceutical at 38.8 subject to Rule 16b-3 | ||
Gregory Bailey over six months ago Acquisition by Gregory Bailey of 25503 shares of Biohaven Pharmaceutical at .1785 subject to Rule 16b-3 |
AGE Old Management Efficiency
The company has Return on Asset of (0.8188) % which means that on every $100 spent on assets, it lost $0.8188. This is way below average. AGE Old's management efficiency ratios could be used to measure how well AGE Old manages its routine affairs as well as how well it operates its assets and liabilities.AGE Old has 4.37 M in debt with debt to equity (D/E) ratio of 0.75, which is OK given its current industry classification. AGE Old has a current ratio of 0.19, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AGE to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Thomas Lynch | Biohaven Pharmaceutical Holding | N/A | |
| Clive Brown | Oxford Nanopore Technologies | N/A | |
| Vladimir MD | Biohaven Pharmaceutical Holding | 54 | |
| Nancy Ruiz | Larimar Therapeutics | N/A | |
| MPH MD | Foghorn Therapeutics | 51 | |
| Peter MD | Invivyd | N/A | |
| Matthew Robinson | Immunome | N/A | |
| William Jones | Biohaven Pharmaceutical Holding | 57 | |
| Rebecca Dabora | Invivyd | 65 | |
| Ben Strain | Foghorn Therapeutics | N/A | |
| Rhodri Davies | Oxford Nanopore Technologies | N/A | |
| Quinn Deveraux | Inhibrx | N/A | |
| Warren Volles | Biohaven Pharmaceutical Holding | N/A | |
| Mark Lappe | Inhibrx | 58 | |
| Alyssa Wyant | Praxis Precision Medicines | 50 | |
| Dennis Giesing | Immunome | 72 | |
| Elyse Stock | Biohaven Pharmaceutical Holding | 63 | |
| Jordan Herman | Oxford Nanopore Technologies | N/A | |
| Gordon Sanghera | Oxford Nanopore Technologies | N/A | |
| Timothy Kelly | Praxis Precision Medicines | 52 | |
| BS CPA | Inhibrx | 42 | |
Management Performance
| Return On Asset | -0.82 |
AGE Old Leadership Team
Elected by the shareholders, the AGE Old's board of directors comprises two types of representatives: AGE Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AGE. The board's role is to monitor AGE Old's management team and ensure that shareholders' interests are well served. AGE Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AGE Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| EunJae CPA, Chief Officer | ||
| Alfred Kingsley, Chairman of the Board | ||
| Judith Segall, Secretary | ||
| Michael West, Chief Executive Officer, Founder, Director | ||
| Aubrey Grey, Vice President - New Technology Discovery | ||
| Gregory Bailey, Independent Chairman of the Board | ||
| Ivan Labat, Chief Information Officer | ||
| Joanne Hackett, Interim Board | ||
| Hal Sternberg, Vice President - Research | ||
| Nafees MD, Chief Officer | ||
| Andrea Park, Chief Financial Officer | ||
| Annalisa Jenkins, Independent Director | ||
| Michael May, Independent Director |
AGE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AGE Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.82 | |||
| Operating Margin | (63.57) % | |||
| Current Valuation | 33.33 M | |||
| Shares Outstanding | 2.5 M | |||
| Shares Owned By Insiders | 75.73 % | |||
| Shares Owned By Institutions | 5.64 % | |||
| Number Of Shares Shorted | 4.47 K | |||
| Price To Earning | (5.95) X | |||
| Price To Book | 12.96 X | |||
| Price To Sales | 221.90 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in AGE Stock
If you are still planning to invest in AGE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AGE Old's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |